Review article: the safety of anticoagulants and antiplatelet agents in patients with cirrhosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Review article: the safety of anticoagulants and antiplatelet agents in patients with cirrhosis

Published:2022-11-14 Issue:1 Volume:57 Page:52-71
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Ma Jiayi¹^ORCID,Chalasani Naga P.¹^ORCID,Schwantes‐An Linus²,Björnsson Einar Stefán³⁴^ORCID

Affiliation:

1. Indiana University School of Medicine and Indiana University Health Indianapolis Indiana USA

2. Indiana University School of Medicine, Medical & Molecular Genetics Indianapolis Indiana USA

3. Department of Gastroenterology Landspitali University Hospital Reykjavik Iceland

4. Faculty of Medicine University of Iceland Reykjavik Iceland

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/apt.17297

Reference101 articles.

1. Risk of Venous Thromboembolism in Patients With Liver Disease: A Nationwide Population-Based Case–Control Study

2. Portal vein thrombosis: Prevalence, patient characteristics and lifetime risk: A population study based on 23 796 consecutive autopsies

3. Atrial fibrillation is highly prevalent yet undertreated in patients with biopsy‐proven nonalcoholic steatohepatitis

4. Long-term follow-up of patients with NAFLD and elevated liver enzymes

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Use of Proton Pump Inhibitors in Patients with Liver Cirrhosis: Real Life Experience;Journal of Clinical Medicine;2024-08-30

2. Comparative Effectiveness and Safety of Ticagrelor and Clopidogrel in Patients With or Without Chronic Liver Disease: A Nationwide Cohort Study;The American Journal of Medicine;2024-08

3. Recommendations for the safe use of direct oral anticoagulants in patients with cirrhosis based on a systematic review of pharmacokinetic, pharmacodynamic and safety data;European Journal of Clinical Pharmacology;2024-03-02

4. A comprehensive framework for managing metabolic dysfunction-associated steatotic liver disease: analyzing novel risk factors and advances in nanotechnology-based treatments and diagnosis;RSC Medicinal Chemistry;2024

5. Improving Management of Portal Hypertension: The Potential Benefit of Non-Etiological Therapies in Cirrhosis;Journal of Clinical Medicine;2023-01-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3